Epidermal Barrier Formation and Recovery in Skin Disorders

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2006 May 4

PMID 16670755

Citations 181

Authors

Julia A Segre

Affiliations

Soon will be listed here.

Abstract

Skin is at the interface between the complex physiology of the body and the external, often hostile, environment, and the semipermeable epidermal barrier prevents both the escape of moisture and the entry of infectious or toxic substances. Newborns with rare congenital barrier defects underscore the skin's essential role in a terrestrial environment and demonstrate the compensatory responses evoked ex utero to reestablish a barrier. Common inflammatory skin disorders such as atopic dermatitis and psoriasis exhibit decreased barrier function, and recent studies suggest that the complex response of epidermal cells to barrier disruption may aggravate, maintain, or even initiate such conditions. Either aiding barrier reestablishment or dampening the epidermal stress response may improve the treatment of these disorders. This Review discusses the molecular regulation of the epidermal barrier as well as causes and potential treatments for defects of barrier formation and proposes that medical management of barrier disruption may positively affect the course of common skin disorders.

Citing Articles

Absolute quantification of the living skin microbiome overcomes relic-DNA bias and reveals specific patterns across volunteers.

Thiruppathy D, Moyne O, Marotz C, Williams M, Navarro P, Zaramela L Microbiome. 2025; 13(1):65.

PMID: 40038838 PMC: 11877739. DOI: 10.1186/s40168-025-02063-4.

Enhancing Transcutaneous Drug Delivery: Advanced Perspectives on Skin Models.

Ribeiro A, Pereira-Leite C, Rosado C, Aruci E, Colley H, Kortekaas Krohn I JID Innov. 2025; 5(2):100340.

PMID: 39925780 PMC: 11803873. DOI: 10.1016/j.xjidi.2024.100340.

Therapeutic potential of phloridzin carbomer gel for skin inflammatory healing in atopic dermatitis.

Lv F, Chen Y, Xie H, Gao M, He R, Deng W Arch Dermatol Res. 2025; 317(1):352.

PMID: 39915288 DOI: 10.1007/s00403-025-03866-z.

Gentiopicroside ameliorates psoriasis-like skin lesions in mice via regulating the Keap1-Nrf2 pathway and inhibiting keratinocyte activation.

Ren J, Chen X, Wang H, Yang T, Zhang K, Lei S Acta Pharmacol Sin. 2025; .

PMID: 39779965 DOI: 10.1038/s41401-024-01449-8.

Metagenomic sequencing of CRISPRs as a new marker to aid in personal identification with low-biomass samples.

Toyomane K, Kimura Y, Fukagawa T, Yamagishi T, Watanabe K, Akutsu T mSystems. 2024; 9(11):e0103824.

PMID: 39470190 PMC: 11575304. DOI: 10.1128/msystems.01038-24.

References

Cookson W . The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol. 2004; 4(12):978-88. DOI: 10.1038/nri1500. View

Suetake T, Sasai S, Zhen Y, Ohi T, Tagami H . Functional analyses of the stratum corneum in scars. Sequential studies after injury and comparison among keloids, hypertrophic scars, and atrophic scars. Arch Dermatol. 1996; 132(12):1453-8. View

Fuchs E, Raghavan S . Getting under the skin of epidermal morphogenesis. Nat Rev Genet. 2002; 3(3):199-209. DOI: 10.1038/nrg758. View

Martin N, Patel S, Segre J . Long-range comparison of human and mouse Sprr loci to identify conserved noncoding sequences involved in coordinate regulation. Genome Res. 2004; 14(12):2430-8. PMC: 534667. DOI: 10.1101/gr.2709404. View

Ghadially R, Reed J, Elias P . Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol. 1996; 107(4):558-64. DOI: 10.1111/1523-1747.ep12582813. View

WOOD L, Jackson S, Elias P, Grunfeld C, Feingold K . Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 1992; 90(2):482-7. PMC: 443124. DOI: 10.1172/JCI115884. View

Soumelis V, Reche P, Kanzler H, Yuan W, Edward G, Homey B . Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 2002; 3(7):673-80. DOI: 10.1038/ni805. View

Steinert P . The complexity and redundancy of epithelial barrier function. J Cell Biol. 2000; 151(2):F5-8. PMC: 2192645. DOI: 10.1083/jcb.151.2.f5. View

Esche C, Benedetto A, Beck L . Keratinocytes in atopic dermatitis: inflammatory signals. Curr Allergy Asthma Rep. 2004; 4(4):276-84. DOI: 10.1007/s11882-004-0071-8. View

10.

WOOD L, Elias P, Calhoun C, Tsai J, Grunfeld C, Feingold K . Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol. 1996; 106(3):397-403. DOI: 10.1111/1523-1747.ep12343392. View

11.

Lee T, Rinaldi N, Robert F, Odom D, Bar-Joseph Z, Gerber G . Transcriptional regulatory networks in Saccharomyces cerevisiae. Science. 2002; 298(5594):799-804. DOI: 10.1126/science.1075090. View

12.

Helms C, Cao L, Krueger J, Wijsman E, Chamian F, Gordon D . A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet. 2003; 35(4):349-56. DOI: 10.1038/ng1268. View

13.

Nickoloff B, Naidu Y . Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol. 1994; 30(4):535-46. DOI: 10.1016/s0190-9622(94)70059-1. View

14.

Nickoloff B, Nestle F . Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest. 2004; 113(12):1664-75. PMC: 420513. DOI: 10.1172/JCI22147. View

15.

Aszterbaum M, Feingold K, Menon G, Williams M . Glucocorticoids accelerate fetal maturation of the epidermal permeability barrier in the rat. J Clin Invest. 1993; 91(6):2703-8. PMC: 443334. DOI: 10.1172/JCI116509. View

16.

Lefevre C, Audebert S, Jobard F, Bouadjar B, Lakhdar H, Boughdene-Stambouli O . Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2. Hum Mol Genet. 2003; 12(18):2369-78. DOI: 10.1093/hmg/ddg235. View

17.

Hardman M, Sisi P, Banbury D, Byrne C . Patterned acquisition of skin barrier function during development. Development. 1998; 125(8):1541-52. DOI: 10.1242/dev.125.8.1541. View

18.

Leung D, Boguniewicz M, Howell M, Nomura I, Hamid Q . New insights into atopic dermatitis. J Clin Invest. 2004; 113(5):651-7. PMC: 351324. DOI: 10.1172/JCI21060. View

19.

Kelsell D, Norgett E, Unsworth H, Teh M, Cullup T, Mein C . Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am J Hum Genet. 2005; 76(5):794-803. PMC: 1199369. DOI: 10.1086/429844. View

20.

Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S . Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet. 2003; 35(3):238-45. DOI: 10.1038/ng1248. View